Boston, MA -- (SBWIRE) -- 08/30/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: (Smith & Wesson Holding Corporation (NASDAQ:SWHC), K12 Inc. (NYSE:LRN), SUPERVALU INC.(NYSE:SVU), Raptor Pharmaceutical Corp.(NASDAQ:RPTP)
Smith & Wesson Holding Corporation (NASDAQ:SWHC) shares gained 2.36% to $11.06. The company on August 19 announced that it has successfully completed a new $75 million unsecured revolving credit facility (the "Credit Facility") that is expandable under an accordion feature that allows, in certain circumstances, for the company to increase the size of the Credit Facility in $25 million increments up to a maximum loan of $175 million.
Additionally, the company announced that it plans to release its first quarter fiscal 2014 financial results on Thursday, September 5, after the close of the market.
How Should Investors Trade SWHC After The Recent Volatility? Get Free Report Here
K12 Inc. (NYSE:LRN) shares gained 11.23% to $35.55. The company on August 29 announced its results for the fourth fiscal quarter and full fiscal year ended June 30, 2013. Revenues for the fiscal year ended June 30, 2013 grew 19.7% to $848.2 million, primarily due to a 12.7% increase in average student enrollments and an increase in average revenue per student in our managed public schools business. Net income attributable to common and Series A stockholders grew by 60.6% to $28.1 million. Diluted net income attributable to common stockholders per share, which reflects a pro rata allocation of net income to Series A stockholders, grew 60.0% to $0.72.
How Should Investors Trade LRN After The Recent Volatility? Get Free Report Here
SUPERVALU INC.(NYSE:SVU) shares climbed 3.85% to $7.29. The company on July 24 announced that as soon as practicable on or following August 7, 2013 the Company will grant Mr. Bruce Besanko stock options to acquire 225,000 shares of Company common stock with an exercise price equal to the closing price of a share of Company common stock on the New York Stock Exchange on the grant date and 225,000 restricted stock shares of Company common stock.
Additionally, the company on July 18 posted first-quarter net earnings of $85 million, or $0.34 a share. Adjusted first-quarter fiscal 2014 net earnings from continuing operations totaled $34 million, or $0.14 a share. Quarterly net sales were $5.16 billion, compared with $5.24 billion last year. Analysts expected earnings per share of $0.06 on revenues of $5.17 billion for the quarter.
Is SVU A Good Buy After The Recent Price Movement? Find Out Here
Raptor Pharmaceutical Corp.(NASDAQ:RPTP) shares gained 3.93% to $13.22. The company on August 29 announced that PROCYSBI (cysteamine bitartrate) will be featured in an upcoming presentation at the 16th Congress of the International Pediatric Nephrology Association being held in Shanghai, China. The presentation, titled "Extended treatment of patients with cystinosis and CKD with RP103 demonstrates efficacy and safety," will be given by Dr. Craig Langman of the Northwestern University Feinberg School of Medicine and is scheduled for 5:15 p.m. China Standard Time on Sunday, September 1, 2013 (Abstract O-42).
Is RPTP A Strong Buy? Get Advantage Of Our Free Trend Analysis Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)